Dose-escalation by Hypofractionated Stereotactic Radiotherapy Simultaneous Integrated Boost IMRT for Brain Metastases in Non Small Cell Lung Cancer：A Phase I Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT05588206

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:38:56.677954+00:00

Published At

2022-10-20T00:00:00+00:00

Record Updated At

2022-10-20

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Non Small Cell Lung Cancer", "Stage IV Non-small Cell Lung Cancer", "Brain Metastases"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2022-10-20"

protocolSection.identificationModule.nctId

"NCT05588206"

protocolSection.identificationModule.officialTitle

"Dose-escalation by Hypofractionated Stereotactic Radiotherapy Simultaneous Integrated Boost IMRT for Brain Metastases in Non Small Cell Lung Cancer\uff1aA Phase I Study"

protocolSection.statusModule.overallStatus

"UNKNOWN"

protocolSection.designModule.phases

["PHASE1", "PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Non Small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
• Stage IV Non-small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
• Brain Metastases (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.